LIGAND PHARMACEUTICALS INCORPORATED Equity Securities FVNINoncurrent
LIGAND PHARMACEUTICALS INCORPORATED (LGNZZ) had Equity Securities FVNINoncurrent of $33.10 million as of 2023-09-30, per its 10-Q filed 2023-11-09.
Discontinued › Balance Sheet › Assets › Assets, Noncurrent › Long-Term Investments and Receivables, Net
us-gaap:EquitySecuritiesFVNINoncurrent · last filed 2023-11-09
- 2023-09-30: Equity Securities FVNINoncurrent $33.10M.
- 2022-12-31: Equity Securities FVNINoncurrent $0.00.
| Period end | Equity Securities FVNINoncurrent |
|---|---|
| 2023-09-30 | $33.10M 10-Q · filed 2023-11-09 |
| 2022-12-31 | $0.00 10-Q · filed 2023-11-09 |